Convergence: Regulators, experts weigh dedicated patient experience section in drug labels
Regulatory NewsEmily Hayes
Advertising, Promotion and LabelingBiologics/ biosimilars/ vaccinesEuropePatient reported outcomesPatient voicePatient-focused drug developmentPharmaceuticalsUnited States